Molecular nanotechnology has emerged as a revolutionary force in the pharmaceutical field, offering unprecedented opportunities for targeted drug delivery, diagnostics, and therapeutic interventions. At the molecular level, nanotechnology enables the design and fabrication of nanoscale devices, allowing for precise manipulation of biological systems. In the realm of drug delivery, nanotechnology facilitates the creation of nanocarriers that can transport therapeutic agents directly to the target site, enhancing drug efficacy while minimizing side effects.
Moreover, the development of nanoscale imaging tools enables detailed visualization of cellular and molecular processes, aiding in early disease detection and personalized medicine. The integration of molecular nanotechnology in pharmaceutical research holds the promise of optimizing drug formulations, improving treatment outcomes, and advancing our understanding of complex biological pathways. As this cutting-edge technology continues to evolve, it is poised to redefine the landscape of the pharmaceutical industry, providing innovative solutions to some of the most challenging medical issues.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary